CAMBRIDGE, Mass.--(BUSINESS WIRE)--Xbiome Inc., an industry leading AI driven microbiome therapeutics company, today announced that it has acquired the clinical-stage M201 program from Assembly ...
FOSTER CITY, Calif. & HAYWARD, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) and Arcus Biosciences, Inc. (NYSE: RCUS) today announced that Gilead has exercised its options to three ...
USDA initiated sign-up for Stage 2 of the Supplemental Disaster Relief Program at local Farm Service Agency offices on Nov. 24, with sign-up to continue until April 30, 2026. Just over $16 billion is ...
An early-stage drug development program was defined as development of a specific drug for a specific indication. Programs in discovery, preclinical development, or early clinical testing between ...